302440 — SK Bioscience Co Share News
0.000.00%
Last trade - 00:00- KR₩3tn
- KR₩3tn
- KR₩651bn
Brief: Sk Bioscience Wins 68 Billion Won Order
Novavax posts quarterly profit on COVID vaccine sales (updated)
South Korea biopharma stocks jump on rising COVID cases
Brief: Sk Bioscience Q2 Operating Loss 35.3 Billion Won, Swings To Loss From Year Earlier
Brief: Sk Bioscience In-House Developed Covid-19 Vaccine Skycovione Approved For Emergency Use Listing By Who
Brief: Sk Bioscience Wins 26 Billion Won Order
Brief: Sk Bioscience Receives Approval For Skycovion Covid-19 Vaccine From Uk’S Mhra
Refinitiv Newscasts - Asia Insight: South Korea's monthly factory output jumps by the most in nearly three years
Brief: Sk Bioscience Q1 Operating Loss 29 Billion Won, Swings To Loss From Year Earlier
Brief: Sk Bioscience Plans To Invest About 2.4 Trln Won Through 2027
Brief: Sk Bioscience Announces Largest Investment Ever To Establish Songdo Global Research & Process Development Center
Brief: SK Bioscience To Invest 284 Billion Won In Research & Process Development Center In S.Korea
Brief: Sk Bioscience's Zoster Vaccine Receives Biologics License Application Approval In Malaysia
FT
SK Bioscience chief says "national pride" prevents China from accepting foreign COVID vaccines- FT
Brief: SK Bioscience And CEPI Sign Agreement To Develop Mrna Vaccines
Novavax gains as partner files for COVID booster approval in S.Korea
Brief: Novavax Says Co, SK Bioscience File Post Approval Change Application In South Korea For Nuvaxovid Covid Vaccine As Booster In Adults Aged 18 & Older-Statement
Bill Gates, South Korea expand global health partnership (updated)